InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,463.37
(
-0.18%
)
US TECH 100
19,228.40
(
-0.16%
)
Dow Jones
39,142.38
(
0.02%
)
Brent Oil
84.41
(
-0.70%
)
Bitcoin
64,031.05
(
-1.22%
)
Post# of 182955
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Buyfor1sell for2

Send PM Follow Ignore
Followers 23
Posts 3749
Boards Moderated 0
Alias Born 05/15/2014

Buyfor1sell for2

Re: crudeoil24 post# 144382

Tuesday, 07/14/2020 8:06:03 AM

Tuesday, July 14, 2020 8:06:03 AM

Post# of 182955
TTOO news On June 30, 2020, T2 Bioystems, Inc. (the “Company”) announced the US launch of its COVID-19 molecular diagnostic test, the T2SARS-CoV-2 Panel, after validation of the test meeting the United States Food and Drug Administration’s (FDA’s) requirements for an Emergency Use Authorization (EUA). On July 1, 2020, the Company submitted an EUA request to the FDA for the T2SARS-CoV-2 Panel.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up